These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33119591)

  • 61. Costs of streamlined HIV care delivery in rural Ugandan and Kenyan clinics in the SEARCH Studys.
    Shade SB; Osmand T; Luo A; Aine R; Assurah E; Mwebaza B; Mwai D; Owaraganise A; Mwangwa F; Ayieko J; Black D; Brown LB; Clark TD; Kwarisiima D; Thirumurthy H; Cohen CR; Bukusi EA; Charlebois ED; Balzer L; Kamya MR; Petersen ML; Havlir DV; Jain V
    AIDS; 2018 Sep; 32(15):2179-2188. PubMed ID: 30134294
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African Developing country setting.
    Mansergh G; Haddix AC; Steketee RW; Nieburg PI; Hu DJ; Simonds RJ; Rogers M
    JAMA; 1996 Jul; 276(2):139-45. PubMed ID: 8656506
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Cost and Threshold Analysis of Retention in Care (RiC): A Multi-Site National HIV Care Program.
    Maulsby C; Jain KM; Weir BW; Enobun B; Riordan M; Charles VE; ; Holtgrave DR
    AIDS Behav; 2017 Mar; 21(3):643-649. PubMed ID: 27873083
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluation of a routine point-of-care intervention for early infant diagnosis of HIV: an observational study in eight African countries.
    Bianchi F; Cohn J; Sacks E; Bailey R; Lemaire JF; Machekano R;
    Lancet HIV; 2019 Jun; 6(6):e373-e381. PubMed ID: 30987937
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The economics of effective AIDS treatment in Thailand.
    Over M; Revenga A; Masaki E; Peerapatanapokin W; Gold J; Tangcharoensathien V; Thanprasertsuk S
    AIDS; 2007 Jul; 21 Suppl 4():S105-16. PubMed ID: 17620745
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Provider cost analysis supports results-based contracting out of maternal and newborn health services: an evidence-based policy perspective.
    Hatcher P; Shaikh S; Fazli H; Zaidi S; Riaz A
    BMC Health Serv Res; 2014 Nov; 14():459. PubMed ID: 25391691
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The changing direct costs of medical care for patients with HIV/AIDS, 1995-2001.
    Krentz HB; Auld MC; Gill MJ;
    CMAJ; 2003 Jul; 169(2):106-10. PubMed ID: 12874156
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Financing HIV service provision in England: estimated impact of the cost of antiretroviral combination therapy.
    Beck EJ; Tolley K
    Int J STD AIDS; 1998 Sep; 9(9):512-7. PubMed ID: 9764934
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Patient costs of accessing collaborative tuberculosis and human immunodeficiency virus interventions in Ethiopia.
    Vassall A; Seme A; Compernolle P; Meheus F
    Int J Tuberc Lung Dis; 2010 May; 14(5):604-10. PubMed ID: 20392354
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The cost of providing combined prevention and treatment services, including ART, to female sex workers in Burkina Faso.
    Cianci F; Sweeney S; Konate I; Nagot N; Low A; Mayaud P; Vickerman P
    PLoS One; 2014; 9(6):e100107. PubMed ID: 24950185
    [TBL] [Abstract][Full Text] [Related]  

  • 71. HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries.
    Marseille E; Dandona L; Marshall N; Gaist P; Bautista-Arredondo S; Rollins B; Bertozzi SM; Coovadia J; Saba J; Lioznov D; Du Plessis JA; Krupitsky E; Stanley N; Over M; Peryshkina A; Kumar SG; Muyingo S; Pitter C; Lundberg M; Kahn JG
    BMC Health Serv Res; 2007 Jul; 7():108. PubMed ID: 17626616
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Economic costs and health-related quality of life outcomes of hospitalised patients with high HIV prevalence: A prospective hospital cohort study in Malawi.
    Maheswaran H; Petrou S; Cohen D; MacPherson P; Kumwenda F; Lalloo DG; Corbett EL; Clarke A
    PLoS One; 2018; 13(3):e0192991. PubMed ID: 29543818
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The size and distribution of key populations at greater risk of HIV in Pakistan: implications for resource allocation for scaling up HIV prevention programmes.
    Emmanuel F; Thompson LH; Salim M; Akhtar N; Reza TE; Hafeez H; Ahmed S; Blanchard JF
    Sex Transm Infect; 2013 Sep; 89 Suppl 2(Suppl 2):ii11-7. PubMed ID: 23843454
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cost of Human Immunodeficiency Virus (HIV) and Determinants of Healthcare Costs in HIV-Infected Treatment-Naive Patients Initiated on Antiretroviral Therapy in Germany: Experiences of the PROPHET Study.
    Valbert F; Wolf E; Schewe K; Klauke S; Hanhoff N; Hoffmann C; Preis S; Pahmeier K; Wasem J; Neumann A
    Value Health; 2020 Oct; 23(10):1324-1331. PubMed ID: 33032776
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Superior outcomes and lower outpatient costs with scale-up of antiretroviral therapy at the GHESKIO clinic in Port-au-Prince, Haiti.
    Riviere C; Faust E; Miller T; Beck EJ; Baruwa E; Severe P; Severe K; Riché CT; Cassagnol R; Atwood S; Esperance M; Webster L; Cremieux P; Pape JW; Koenig SP
    J Acquir Immune Defic Syndr; 2014 Aug; 66(4):e72-9. PubMed ID: 24984189
    [TBL] [Abstract][Full Text] [Related]  

  • 76. In the interests of time: improving HIV allocative efficiency modelling via optimal time-varying allocations.
    Shattock AJ; Kerr CC; Stuart RM; Masaki E; Fraser N; Benedikt C; Gorgens M; Wilson DP; Gray RT
    J Int AIDS Soc; 2016; 19(1):20627. PubMed ID: 26928810
    [TBL] [Abstract][Full Text] [Related]  

  • 77. National Evaluation of HIV Service Resource Allocation in Tanzania.
    McBain RK; Jordan M; Mann C; Ruhago GM; Lee B; Forsythe S; Stewart K; Brown J; Nandakumar A
    AIDS Behav; 2023 Oct; 27(10):3498-3507. PubMed ID: 37145288
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Counting the cost of not costing HIV health facilities accurately: pay now, or pay more later.
    Beck EJ; Avila C; Gerbase S; Harling G; De Lay P
    Pharmacoeconomics; 2012 Oct; 30(10):887-902. PubMed ID: 22830633
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Economic impact of HIV and antiretroviral therapy on education supply in high prevalence regions.
    Risley CL; Drake LJ; Bundy DA
    PLoS One; 2012; 7(11):e42909. PubMed ID: 23173030
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The influence of constraints on the efficient allocation of resources for HIV prevention.
    Stopard IJ; McGillen JB; Hauck K; Hallett TB
    AIDS; 2019 Jun; 33(7):1241-1246. PubMed ID: 30649065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.